Application 021227
- Type
- NDA
- Sponsor
- MERCK
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | CANCIDAS | CASPOFUNGIN ACETATE | POWDER;INTRAVENOUS | 50MG/VIAL | Yes | Yes |
| 002 | CANCIDAS | CASPOFUNGIN ACETATE | POWDER;INTRAVENOUS | 70MG/VIAL | Yes | Yes |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N021227-001 | CANCIDAS | CASPOFUNGIN ACETATE | 50MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | POWDER / INTRAVENOUS | RLD | 2001-01-26 | |
| N021227-002 | CANCIDAS | CASPOFUNGIN ACETATE | 70MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | POWDER / INTRAVENOUS | RLD | 2001-01-26 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-10-15 13:18:30 | 2026-09 | N021227-001 | CANCIDAS | 50MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | POWDER / INTRAVENOUS | RLD | 2001-01-26 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | N021227-002 | CANCIDAS | 70MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | POWDER / INTRAVENOUS | RLD | 2001-01-26 | c2088c7a36db… | |
| 2026-09-14 22:38:34 | 2026-08 | N021227-001 | CANCIDAS | 50MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | POWDER / INTRAVENOUS | RLD | 2001-01-26 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N021227-002 | CANCIDAS | 70MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | POWDER / INTRAVENOUS | RLD | 2001-01-26 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | N021227-001 | CANCIDAS | 50MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | POWDER / INTRAVENOUS | RLD | 2001-01-26 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N021227-002 | CANCIDAS | 70MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | POWDER / INTRAVENOUS | RLD | 2001-01-26 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | N021227-001 | CANCIDAS | 50MG/VIAL | POWDER / INTRAVENOUS | RLD | 2001-01-26 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N021227-002 | CANCIDAS | 70MG/VIAL | POWDER / INTRAVENOUS | RLD | 2001-01-26 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021227-001 | CANCIDAS | 50MG/VIAL | POWDER / INTRAVENOUS | RLD | 2001-01-26 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021227-002 | CANCIDAS | 70MG/VIAL | POWDER / INTRAVENOUS | RLD | 2001-01-26 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N021227-001 | CANCIDAS | 50MG/VIAL | POWDER / INTRAVENOUS | RLD | 2001-01-26 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N021227-002 | CANCIDAS | 70MG/VIAL | POWDER / INTRAVENOUS | RLD | 2001-01-26 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N021227-001 | CANCIDAS | 50MG/VIAL | POWDER / INTRAVENOUS | RLD | 2001-01-26 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N021227-002 | CANCIDAS | 70MG/VIAL | POWDER / INTRAVENOUS | RLD | 2001-01-26 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N021227-001 | CANCIDAS | 50MG/VIAL | POWDER / INTRAVENOUS | RLD | 2001-01-26 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N021227-002 | CANCIDAS | 70MG/VIAL | POWDER / INTRAVENOUS | RLD | 2001-01-26 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N021227-001 | CANCIDAS | 50MG/VIAL | POWDER / INTRAVENOUS | RLD | 2001-01-26 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N021227-002 | CANCIDAS | 70MG/VIAL | POWDER / INTRAVENOUS | RLD | 2001-01-26 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N021227-001 | CANCIDAS | 50MG/VIAL | POWDER / INTRAVENOUS | AP | RLD, RS | 2001-01-26 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N021227-002 | CANCIDAS | 70MG/VIAL | POWDER / INTRAVENOUS | AP | RLD, RS | 2001-01-26 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N021227-001 | CANCIDAS | 50MG/VIAL | POWDER / INTRAVENOUS | AP | RLD, RS | 2001-01-26 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N021227-002 | CANCIDAS | 70MG/VIAL | POWDER / INTRAVENOUS | AP | RLD, RS | 2001-01-26 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N021227-001 | CANCIDAS | 50MG/VIAL | POWDER / INTRAVENOUS | AP | RLD, RS | 2001-01-26 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N021227-002 | CANCIDAS | 70MG/VIAL | POWDER / INTRAVENOUS | AP | RLD, RS | 2001-01-26 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | N021227-001 | CANCIDAS | 50MG/VIAL | POWDER / INTRAVENOUS | AP | RLD, RS | 2001-01-26 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | N021227-002 | CANCIDAS | 70MG/VIAL | POWDER / INTRAVENOUS | AP | RLD, RS | 2001-01-26 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N021227-001 | CANCIDAS | 50MG/VIAL | POWDER / INTRAVENOUS | AP | RLD, RS | 2001-01-26 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N021227-002 | CANCIDAS | 70MG/VIAL | POWDER / INTRAVENOUS | AP | RLD, RS | 2001-01-26 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N021227-001 | CANCIDAS | 50MG/VIAL | POWDER / INTRAVENOUS | AP | RLD, RS | 2001-01-26 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N021227-002 | CANCIDAS | 70MG/VIAL | POWDER / INTRAVENOUS | AP | RLD, RS | 2001-01-26 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N021227-001 | CANCIDAS | 50MG/VIAL | POWDER / INTRAVENOUS | AP | RLD, RS | 2001-01-26 | 1e350fbaab3a… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N021227-002 | CANCIDAS | 70MG/VIAL | POWDER / INTRAVENOUS | AP | RLD, RS | 2001-01-26 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | N021227-001 | CANCIDAS | 50MG/VIAL | POWDER / INTRAVENOUS | AP | RLD, RS | 2001-01-26 | 8072bd15b7f6… |
| 2024-05-31 18:47 UTC | 2024-05 | N021227-002 | CANCIDAS | 70MG/VIAL | POWDER / INTRAVENOUS | AP | RLD, RS | 2001-01-26 | 8072bd15b7f6… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N021227-001 | CANCIDAS | 50MG/VIAL | POWDER / INTRAVENOUS | AP | RLD, RS | 2001-01-26 | 5c6f7cd8ea54… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N021227-002 | CANCIDAS | 70MG/VIAL | POWDER / INTRAVENOUS | AP | RLD, RS | 2001-01-26 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | N021227-001 | CANCIDAS | 50MG/VIAL | POWDER / INTRAVENOUS | AP | RLD, RS | 2001-01-26 | 5d02ea3f76ae… |
| 2022-04-08 23:34 UTC | 2022-04 | N021227-002 | CANCIDAS | 70MG/VIAL | POWDER / INTRAVENOUS | AP | RLD, RS | 2001-01-26 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | N021227-001 | CANCIDAS | 50MG/VIAL | POWDER / INTRAVENOUS | AP | RLD, RS | 2001-01-26 | 4b0b4de00fa7… |
| 2022-04-04 05:41 UTC | 2022-04 | N021227-002 | CANCIDAS | 70MG/VIAL | POWDER / INTRAVENOUS | AP | RLD, RS | 2001-01-26 | 4b0b4de00fa7… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N021227-001 | AP | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N021227-002 | AP | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N021227-001 | AP | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N021227-002 | AP | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N021227-001 | AP | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N021227-002 | AP | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | N021227-001 | AP | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | N021227-002 | AP | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N021227-001 | AP | 1 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N021227-002 | AP | 1 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N021227-001 | AP | 1 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N021227-002 | AP | 1 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N021227-001 | AP | 1 | 1e350fbaab3a… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N021227-002 | AP | 1 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | N021227-001 | AP | 1 | 8072bd15b7f6… |
| 2024-05-31 18:47 UTC | 2024-05 | N021227-002 | AP | 1 | 8072bd15b7f6… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N021227-001 | AP | 1 | 5c6f7cd8ea54… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N021227-002 | AP | 1 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | N021227-001 | AP | 1 | 5d02ea3f76ae… |
| 2022-04-08 23:34 UTC | 2022-04 | N021227-002 | AP | 1 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | N021227-001 | AP | 1 | 4b0b4de00fa7… |
| 2022-04-04 05:41 UTC | 2022-04 | N021227-002 | AP | 1 | 4b0b4de00fa7… |
| 2019-12-13 00:20 UTC | 2019-12 | N021227-001 | AP | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | N021227-002 | AP | 1 | 74a2ff9319b5… |
| 2022-03-09 01:35 UTC | 2022-03 | N021227-001 | AP | 1 | bb7c543d1eb4… |
| 2022-03-09 01:35 UTC | 2022-03 | N021227-002 | AP | 1 | bb7c543d1eb4… |
| 2021-12-28 21:50 UTC | 2021-12 | N021227-001 | AP | 1 | 782e0a99824c… |
| 2021-12-28 21:50 UTC | 2021-12 | N021227-002 | AP | 1 | 782e0a99824c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N021227-001 | AP | 1 | 87673890dc5c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N021227-002 | AP | 1 | 87673890dc5c… |
| 2021-03-12 10:30 UTC | 2021-03 | N021227-001 | AP | 1 | 5aa47cf7b7d7… |
| 2021-03-12 10:30 UTC | 2021-03 | N021227-002 | AP | 1 | 5aa47cf7b7d7… |
| 2020-12-22 03:56 UTC | 2020-12 | N021227-001 | AP | 1 | 8869cabd3fbd… |
| 2020-12-22 03:56 UTC | 2020-12 | N021227-002 | AP | 1 | 8869cabd3fbd… |
| 2020-11-12 02:37 UTC | 2020-11 | N021227-001 | AP | 1 | c0c555d07b60… |
| 2020-11-12 02:37 UTC | 2020-11 | N021227-002 | AP | 1 | c0c555d07b60… |
| 2019-12-14 00:12 UTC | 2019-12 | N021227-001 | AP | 1 | 3f01610625f2… |
| 2019-12-14 00:12 UTC | 2019-12 | N021227-002 | AP | 1 | 3f01610625f2… |
| 2019-09-15 20:21 UTC | 2019-09 | N021227-001 | AP | 1 | b00525d2431f… |
| 2019-09-15 20:21 UTC | 2019-09 | N021227-002 | AP | 1 | b00525d2431f… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Caspofungin Acetate | CASPOFUNGIN ACETATE | Sagent Pharmaceuticals | 08fb61ee-a05a-4ce1-934c-8cd26c5733db | 2026-07-29 | Warnings, Adverse reactions | CASPOFUNGIN ACETATE |
| Caspofungin Acetate | CASPOFUNGIN ACETATE | Fresenius Kabi USA, LLC | e76d8d83-3691-451c-a32c-d91448c54d16 | 2026-01-08 | Warnings, Adverse reactions | CASPOFUNGIN ACETATE |
| CASPOFUNGIN ACETATE | CASPOFUNGIN ACETATE | Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. | 2b9bf716-9d4b-4264-985b-6fe98f5e729d | 2025-10-08 | Warnings, Adverse reactions | CASPOFUNGIN ACETATE |
| Caspofungin Acetate | CASPOFUNGIN ACETATE | Fosun Pharma USA Inc. | cbd33696-e059-4e27-a782-95e23e8159b8 | 2022-03-21 | Warnings, Adverse reactions | CASPOFUNGIN ACETATE |
| CASPOFUNGIN ACETATE | CASPOFUNGIN ACETATE | Sandoz Inc | 722facc6-d4ea-4975-b83e-3ae63df69ed2 | 2022-01-31 | Warnings, Adverse reactions | CASPOFUNGIN ACETATE |
| Caspofungin Acetate | CASPOFUNGIN ACETATE | Gland Pharma Limited | 29da357e-e7fc-46af-bf20-806a1e4b5391 | 2022-01-19 | Warnings, Adverse reactions | CASPOFUNGIN ACETATE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0006-3822 | CANCIDAS | CASPOFUNGIN ACETATE | Merck Sharp & Dohme Corp. | NDA | Current |
| 0006-3822 | CANCIDAS | CASPOFUNGIN ACETATE | Merck Sharp & Dohme Corp. | NDA | Current |
| 0006-3822 | CANCIDAS | CASPOFUNGIN ACETATE | Merck Sharp & Dohme Corp. | NDA | Current |
| 0006-3822 | CANCIDAS | CASPOFUNGIN ACETATE | Merck Sharp & Dohme Corp. | NDA | Current |
| 0006-3822 | CANCIDAS | CASPOFUNGIN ACETATE | Merck Sharp & Dohme LLC | NDA | Current |
| 0006-3823 | CANCIDAS | CASPOFUNGIN ACETATE | Merck Sharp & Dohme Corp. | NDA | Current |
| 0006-3823 | CANCIDAS | CASPOFUNGIN ACETATE | Merck Sharp & Dohme Corp. | NDA | Current |
| 0006-3823 | CANCIDAS | CASPOFUNGIN ACETATE | Merck Sharp & Dohme Corp. | NDA | Current |
| 0006-3823 | CANCIDAS | CASPOFUNGIN ACETATE | Merck Sharp & Dohme Corp. | NDA | Current |
| 0006-3823 | CANCIDAS | CASPOFUNGIN ACETATE | Merck Sharp & Dohme LLC | NDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 69538 | SUPPL | 2021-12-13 |
| 69111 | SUPPL | 2021-10-26 |
| 57713 | SUPPL | 2019-02-20 |
| 57500 | SUPPL | 2019-02-12 |
| 52988 | SUPPL | 2018-03-15 |
| 52978 | SUPPL | 2018-03-15 |
| 49624 | SUPPL | 2017-08-30 |
| 49560 | SUPPL | 2017-08-25 |
| 49403 | SUPPL | 2017-08-15 |
| 49340 | SUPPL | 2017-08-11 |
| 27136 | SUPPL | 2016-04-14 |
| 4700 | SUPPL | 2016-04-14 |
| 36414 | SUPPL | 2016-04-13 |
| 14679 | SUPPL | 2016-04-13 |
| 36413 | SUPPL | 2014-11-18 |
| 27135 | SUPPL | 2014-10-27 |
| 36412 | SUPPL | 2013-08-06 |
| 4698 | SUPPL | 2013-08-05 |
| 14678 | SUPPL | 2013-01-11 |
| 4699 | SUPPL | 2013-01-10 |
| 27134 | SUPPL | 2012-05-02 |
| 4697 | SUPPL | 2010-11-02 |
| 36411 | SUPPL | 2010-10-25 |
| 4696 | SUPPL | 2010-02-05 |
| 14677 | SUPPL | 2010-02-04 |
| 27132 | SUPPL | 2009-06-30 |
| 14676 | SUPPL | 2009-06-29 |
| 27133 | SUPPL | 2009-05-07 |
| 36410 | SUPPL | 2008-08-13 |
| 21525 | SUPPL | 2008-07-31 |
| 4694 | SUPPL | 2008-07-31 |
| 4695 | SUPPL | 2008-07-24 |
| 51284 | SUPPL | 2007-08-15 |
| 36409 | SUPPL | 2005-02-17 |
| 27131 | SUPPL | 2005-02-17 |
| 36407 | SUPPL | 2004-10-04 |
| 27130 | SUPPL | 2004-10-04 |
| 4691 | SUPPL | 2004-05-28 |
| 36408 | SUPPL | 2004-04-05 |
| 14675 | SUPPL | 2004-04-05 |
| 4693 | SUPPL | 2004-03-24 |
| 4692 | SUPPL | 2004-03-24 |
| 36406 | SUPPL | 2003-03-07 |
| 36405 | SUPPL | 2002-11-21 |
| 27129 | SUPPL | 2002-11-21 |
| 36404 | SUPPL | 2002-09-20 |
| 27128 | SUPPL | 2002-09-20 |
| 14674 | SUPPL | 2002-09-20 |
| 4690 | SUPPL | 2002-09-20 |
| 42039 | ORIG | 2001-01-26 |
| 14673 | ORIG | 2001-01-26 |
| 4689 | ORIG | 2001-01-26 |
| 58103 | ORIG | 1900-01-01 |
| 54102 | ORIG | 1900-01-01 |
| 54101 | ORIG | 1900-01-01 |
| 54100 | ORIG | 1900-01-01 |